As of 2026-04-02, the Intrinsic Value of BIOAGE Labs Inc (BIOA) is -6.97 USD. This BIOA valuation is based on the model Peter Lynch Fair Value. With the current market price of 17.73 USD, the upside of BIOAGE Labs Inc is -139.29%.
Based on its market price of 17.73 USD and our intrinsic valuation, BIOAGE Labs Inc (BIOA) is overvalued by 139.29%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -6.97 - -6.97 | -6.97 | -139.29% |
| P/E | (4.01) - (14.94) | (4.88) | -127.5% |
| DDM - Stable | (12.71) - (47.55) | (30.13) | -269.9% |
| DDM - Multi | (11.29) - (33.20) | (16.89) | -195.3% |
| Market Cap (mil) | 964.42 |
| Beta | 1.43 |
| Outstanding shares (mil) | 54.39 |
| Enterprise Value (mil) | 752.97 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.16% |
| Cost of Debt | 5.00% |
| WACC | 9.10% |